Asiatic acid-based injectable nanohydrogel attenuates osteoarthritis by disrupting CCL17-associated macrophage–chondrocyte crosstalk
Materials & Design · 2026-12 · 272 · 117433
DOI: 10.1016/j.matdes.2026.117433 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials & Design, 2026-12. Verfasst von Yupeng Chen und 15 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Provincial Natural Science Foundation, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Osteoarthritis (OA) is a prevalent degenerative joint disease-causing pain and disability. To identify anti-inflammatory agents, we screened natural compounds and found asiatic acid (AA) effective against inflammatory macrophage activation, yet its poor solubility and bioavailability limit use. To overcome this, AA was polymerized into poly(asiatic acid) (PAA), self-assembled into nanoparticles (PAA NPs), and further modified with folic acid (FA-PAA NPs) for macrophage targeting. These NPs were incorporated into a hydroxypropyl chitin hydrogel (HPCH) to form an injectable sustained-release platform (FA-PAA@HPCH). This system showed good injectability, temperature-responsive gelation, and prolonged release. FA modification markedly enhanced uptake by inflammatory macrophages. FA-PAA@HPCH suppressed pro-inflammatory macrophage activation, favored an anti-inflammatory macrophage phenotype, and reduced ROS. Antibody microarray analysis identified reduced CCL17 secretion, while transcriptomic analysis implicated TNF-related signaling as a candidate pathway associated with treatment. Recombinant CCL17 partially reversed the protective effects on chondrocytes, supporting a contribution of CCL17 to macrophage–chondrocyte inflammatory communication. In an ACL transection‑induced OA model, FA-PAA@HPCH alleviated synovial inflammation, preserved cartilage, improved subchondral bone, and showed favorable biocompatibility under the tested conditions. Collectively, this study supports further investigation of CCL17-associated inflammatory communication and an AA-based immunomodulatory hydrogel strategy for OA treatment.
Förderung
- Guangdong Provincial Natural Science Foundation
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Chen, Y., Luo, Q., Li, Y., Chen, H., Liu, J., Zhuang, X., Lin, Y., He, W., Li, X., Li, Y., Yu, R., Fan, L., Wang, J., Wu, H., Guan, D., & Liu, Q. (2026). Asiatic acid-based injectable nanohydrogel attenuates osteoarthritis by disrupting CCL17-associated macrophage–chondrocyte crosstalk. Materials & Design, 272, 117433. https://doi.org/10.1016/j.matdes.2026.117433
Vancouver
Chen Y, Luo Q, Li Y, Chen H, Liu J, Zhuang X, et al. Asiatic acid-based injectable nanohydrogel attenuates osteoarthritis by disrupting CCL17-associated macrophage–chondrocyte crosstalk. Materials & Design. 2026;272:117433. doi:10.1016/j.matdes.2026.117433
BibTeX
@article{Chen2026,
author = {Chen, Yupeng and Luo, Qian and Li, Yi and Chen, Haojie and Liu, Jingxin and Zhuang, Xiaoyan and Lin, Yanpeng and He, Wanling and Li, Xiang and Li, Yiwen and Yu, Ruojing and Fan, Liuyi and Wang, Jun and Wu, Hangtian and Guan, Daogang and Liu, Qinwen},
title = {Asiatic acid-based injectable nanohydrogel attenuates osteoarthritis by disrupting CCL17-associated macrophage–chondrocyte crosstalk},
journal = {Materials & Design},
year = {2026},
volume = {272},
pages = {117433},
doi = {10.1016/j.matdes.2026.117433}
}
EUVIMED